APA (7th ed.) Citation

IM, J., P, M., S, Z., MS, S., R, E., F, P., . . . JP, B. (2012). Refinement of stopping rules during treatment of hepatitis C genotype 1 infection with boceprevir and peginterferon/ribavirin. Hepatology (Baltimore, Md.), 56(2), 567. https://doi.org/10.1002/hep.25865

Chicago Style (17th ed.) Citation

IM, Jacobson, et al. "Refinement of Stopping Rules During Treatment of Hepatitis C Genotype 1 Infection with Boceprevir and Peginterferon/ribavirin." Hepatology (Baltimore, Md.) 56, no. 2 (2012): 567. https://doi.org/10.1002/hep.25865.

MLA (9th ed.) Citation

IM, Jacobson, et al. "Refinement of Stopping Rules During Treatment of Hepatitis C Genotype 1 Infection with Boceprevir and Peginterferon/ribavirin." Hepatology (Baltimore, Md.), vol. 56, no. 2, 2012, p. 567, https://doi.org/10.1002/hep.25865.